DETECTION OF DIFFUSE CHANGES IN LIVER ECHOGENICITY IN RHEUMATOID ARTHRITIS PATIENTS USING ULTRASOUND AND ITS PREVENTIVE SIGNIFICANCE

Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints but can also involve internal organs, including the liver. Diffuse changes in liver echogenicity in rheumatoid arthritis patients are often asymptomatic, yet they play a crucial role in assessing disease progression and treatment outcomes. Traditional diagnostic methods, such as laboratory tests and liver biopsy, are invasive and may cause patient discomfort. Ultrasound examination provides a safe, non-invasive, and effective method to detect diffuse hepatic changes. Early identification of these changes allows for timely preventive interventions, reduces the risk of complications, and supports individualized treatment strategies. Integrating ultrasound monitoring into routine care for rheumatoid arthritis patients enhances both liver health and overall therapeutic effectiveness.